AzTrials
AzTrials

Hemiplegic Cerebral PalsyNCT06317935

The Effect of Virtual Reality Application on Independence and Hand Functions in Daily Life in Children With CP

A study testing ArmeoSenso and Traditional Rehabilitation in people with Hemiplegic Cerebral Palsy, run by Hacettepe University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate the effect of virtual reality applications on the level of independence and upper extremity functionality perceived by children in daily life in children with hemipegic cerebral palsy. The research is a randomized controlled, cross-over study. Read more about this study

Who is it for?
Ages 6 to 12 years
Conditions the study is for
Hemiplegic Cerebral Palsy
What is being tested?
ArmeoSenso and Traditional Rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
1 siteTurkey (Türkiye)
Study dates
23 Apr 2024to 29 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • - Having a diagnosis of hemiplegic SP
  • Being between the ages of 6-12
  • Not having any fixed contracture in the upper extremity
  • According to the Modified Ashworth Scale, the upper extremity spasticity value is at the level of 1,1+,2 or 3
  • Being at level I, II or III according to the Gross Motor Function Classification System (GMFCS)
  • Being at level II or III according to the Manual Ability Classification System (MACS)
Show all 11Show fewer
  • Being at level I, II or III according to the Communication Function Classification System (CFCS)
  • Being within the normal cognitive level according to the Modified Pediatrics Mini Mental Test score
  • Being at level I, II or III according to the Eating and Drinking Ability Classification System (EDACS)
  • Being at level I, II or III according to the Visual Function Classification System for Children with Cerabral Palsy (VFCS)
  • Volunteering to participate in the study

Who cannot join

  • Having botolinum toxin injection within the last 6 months
  • Having undergone a surgical procedure within the last 1 year
  • Fracture, trauma, etc. in the upper extremity. to live

Trial locations and contacts

1 site in 1 country.

Başak Karadağ, MSc. contact

+905059462128

karadagbasak@outlook.com

Meral Huri, Professor contact

+905335515590

mrlhuri@gmail.com

Turkey (Türkiye)1 site
  • Ankara Bilkent City Hospital

    Multiple Locations, Ankara, 06000

    Başak Karadağ, MSc, +905059462128, basakhacettepe@hotmail.com

    Berke Aras, Ass. Prof., +90365851518, drberkearas@gmail.com

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Virtual Reality Intervention on Upper Extremity Functioning and Perceived Independence in Daily Life in Children With Hemiplegic Cerebral Palsy

The aim of this study is to evaluate the effect of virtual reality applications on the level of independence and upper extremity functionality perceived by children in daily life in children with hemipegic cerebral palsy.

The research is a randomized controlled, cross-over study. The sample group of the research is children diagnosed with hemiplegic cerebral palsy and families who are receiving inpatient treatment in the pediatric service of Ankara City Hospital Physical Therapy and Rehabilitation Hospital.

Read more

Two groups, intervention (A) and control (B), will be created from the target research group using the randomization method.

The upper extremity functionality of both research groups before the intervention will be evaluated with the 'Motor Activity Diary for Children' scale and the perceived independence level with the 'Children's Hand Use Experience' scale.

After the initial evaluation is completed, group A, represented as the intervention group, will receive ArmeoSenso virtual reality intervention in the upper extremity hand function laboratory for 3 weeks, 5 days a week, each session for 30 minutes, in addition to traditional occupational therapy and physiotherapy rehabilitation programs. Meanwhile, group B, represented as the control group, will continue the traditional occupational therapy and physiotherapy rehabilitation program. At the end of the third week of the intervention, tests measuring upper extremity functionality and perceived independence level will be repeated.

Measurement tools will be repeated at the beginning of the intervention, at the end of the 3rd week, and at the end of the intervention.

Read the detailed description

The sample group of the research is children between the ages of 6-12, diagnosed with hemiplegic cerebral palsy, who are receiving inpatient treatment in the pediatric service of Ankara City Hospital Physical Therapy and Rehabilitation Hospital, and their families.

Statistical power analysis was performed to calculate the number of people required to be included in the study. Statistical power analysis was performed with G*Power v.3.1.9.7 software. In the analysis, the Type 1 error margin (α) was accepted as 5% and the desired statistical power (1-β) was accepted as 0.80. In order to carry out the analysis, randomized controlled studies in the literature on the subject that reported effect sizes were examined. Studies have found that in virtual reality-based interventions applied to children with cerebral palsy, strong to very strong effect sizes were reported between intervention and control groups in variables such as upper extremity functions and performance in daily living activities (4, 7-11). When calculations were made using the strong effect size (Cohen's d = 0.80) in the sample size analysis, it was determined that the smallest sample size that needed to be reached for both groups was 26. Therefore, a total of 52 people were included in the study.

Being tested
ArmeoSenso, Traditional Rehabilitation
Keywords
Virtual Reality, Upper Extremity, Hemiplegic Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ArmeoSensoOther

    ArmeoSenso is an upper extremity virtual reality application with three motion sensors and one hand grip sensor. The device detects the person's body, arm, forearm and hand movements and displays the reflection of the movements on the screen. The application includes studies on upper extremity functions.

  • Traditional RehabilitationOther

    It includes traditional occupational therapy and physiotherapy approaches.

Study groups in NCT06317935
Study groupRoleWhat they receive
ArmeoSensoOtherArmeoSenso virtual reality application will be applied to group A in the 0-3 weeks of the study and to group B in the 3-6 weeks.
Receives: Other: ArmeoSenso; Other: Traditional Rehabilitation
Traditional rehabilitationOtherTraditional rehabilitation (physiotherapy and occupational therapy) approaches will continue to be applied to groups A and B at all stages of the research.
Receives: Other: Traditional Rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The effect of virtual reality applications on perceived independence in daily life in hemiplegic CP.

    The independence levels perceived by children with hemiplegic CP in daily life will be evaluated with the Children's Hand Use Experience Questionnaire.

    Measured: At the end of the 6th week

  2. The effect of virtual reality applications on upper extremity functionality in daily life in children with hemiplegic CP.

    The impact on the upper extremity functionality of children with hemiplegic CP in daily life will be evaluated with the Pediatric Motor Activity Log-Revised test.

    Measured: At the end of the 6th week

Secondary outcomes (1)
  1. Dosimetry of virtual reality applications

    As suggested in further research, examining the dosimetric properties of virtual reality applications such as frequency and duration and comparing them with other studies.

    Measured: At the end of the 6th week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2024
  2. Study start23 Apr 2024 (estimated)
  3. Primary completion29 Jun 2024 (estimated)
  4. Study completion29 Oct 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Model description
Two groups, intervention (A) and control (B), will be created from the target research group using the randomization method. Intervention group (A) will receive virtual reality application for 30 minutes, 5 days a week for 3 weeks, in addition to traditional occupational therapy and physiotherapy approaches for the first 3 weeks, and will receive only traditional treatments between 3-6 weeks. The control group (B) will receive only traditional occupational therapy and physiotherapy approaches for the first 3 weeks, and between 3-6 weeks, they will receive virtual reality application in addition to traditional approaches for 30 minutes, 5 days a week for 3 weeks.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06317935
Sponsor's protocol ID
HU-ERG-BK-01
Status last verified
Mar 2024
First submitted
20 Feb 2024
Last updated
19 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Only the principal investigator can access information about individuals; other researchers will not be able to access this information due to blinding.

Publications

  • Chen YP, Lee SY, Howard AM. Effect of virtual reality on upper extremity function in children with cerebral palsy: a meta-analysis. Pediatr Phys Ther. 2014 Fall;26(3):289-300. doi: 10.1097/PEP.0000000000000046.

    PubMed 24819682
  • Goyal C, Vardhan V, Naqvi W. Virtual Reality-Based Intervention for Enhancing Upper Extremity Function in Children With Hemiplegic Cerebral Palsy: A Literature Review. Cureus. 2022 Jan 28;14(1):e21693. doi: 10.7759/cureus.21693. eCollection 2022 Jan.

    PubMed 35237486

Questions about this trial

What is this clinical trial studying?

A study testing ArmeoSenso and Traditional Rehabilitation in people with Hemiplegic Cerebral Palsy, run by Hacettepe University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Başak Karadağ, MSc. (+905059462128, karadagbasak@outlook.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The effect of virtual reality applications on perceived independence in daily life in hemiplegic CP. (time frame: At the end of the 6th week). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06317935, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in